A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.
-
Page/Page column 39-40
(2010/10/20)
More Articles about upstream products of 69123-51-9